SCHEMBL29926516

SCHEMBL29926516

COC(=O)c1ccc(S(=O)(=O)Cl)cn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.57
KDM4E B2RXH2 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
LMNA P02545 2/20 0.43
LCK P06239 1/20 0.40
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
P4HTM Q9NXG6 1/20 0.39
GABRP O00591 2/20 0.38
GABRD O14764 2/20 0.38
GABRA1 P14867 2/20 0.38
GABRB1 P18505 2/20 0.38
GABRG2 P18507 2/20 0.38
GABRB3 P28472 2/20 0.38
GABRA5 P31644 2/20 0.38
GABRA3 P34903 2/20 0.38
GABRA2 P47869 2/20 0.38
GABRB2 P47870 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3153788 1.00 MAPK1 (0.57) MAPK1KDM4EL3MBTL1LMNALCK
SCHEMBL30555263 0.85 MAPK1 (0.59) MAPK1KDM4EL3MBTL1LMNALCK
SCHEMBL9901479 0.85 MAPK1 (0.59) MAPK1KDM4EL3MBTL1LMNALCK
SCHEMBL2304195 0.83 MAPK1 (0.57) MAPK1KDM4EL3MBTL1LCKCA12
SCHEMBL3451428 0.81 NAMPT (0.46) KDM4EL3MBTL1LMNACA2P4HTM
SCHEMBL12481577 0.81 MAPK1 (0.54) MAPK1KDM4EL3MBTL1LMNALCK
SCHEMBL19249701 0.81 MAPK1 (0.54) MAPK1KDM4EL3MBTL1LMNAP4HTM
SCHEMBL3449352 0.77 KMT2A (0.47) KDM4ELMNALCKCA12CA1
SCHEMBL28005239 0.77 MAPK1 (0.50) MAPK1KDM4EL3MBTL1LMNALCK
SCHEMBL118882 0.77 CA1 (0.61) CA12CA1CA2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115087658-A Sulfonamide or sulfenamide compounds having BRD 4-inducing proteolytic activity, and pharmaceutical use thereof 田边三菱制药株式会社 2022-09-20 CN disclosed